Matthew Helmut Kulke, MD

Specialties

Neuroendocrine tumors, gastrointestinal cancer, carcinoid tumors
Departments

Neuroendocrine Tumor Program, Pancreatic Cancer

My Contact Information

617.638.6428
Primary Location
830 Harrison Avenue
3rd Floor
Boston, MA 02118

More About Me

Matthew H. Kulke, MD is Chief of Hematology/Oncology at Boston Medical Center and Co-Director of the BU/BMC Cancer Center. He is also the Zoltan Kohn Professor at Boston University Chobanian & Avedisian School of Medicine (Boston University Chobanian & Avedisian School of Medicine). Dr. Kulke is internationally recognized for his expertise in neuroendocrine tumors and has led numerous national and international clinical trials resulting in new drugs and therapies for neuroendocrine tumors. Dr. Kulke has published more than 200 peer-reviewed publications on preclinical and clinical research in this area. He is a member of the Shipley Prostate Cancer Research Center at Boston University Chobanian & Avedisian School of Medicine and also the Evans Center for Interdisciplinary Biomedical Research at Boston University.

Administrative Title
Zoltan Kohn Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University. Member, Shipley Prostate Cancer Research Center at Boston University Chobanian and Avedisian School of Medicine.
Education

University of California San Francisco School of Medicine, 1992
Residency
Internal Medicine, Brigham and Women’s Hospital
Fellowship
Medical Oncology, Dana-Farber Cancer Institute
Board Certifications
Medical Oncology, American Board of Internal Medicine
Special Interests
Neuroendocrine tumors, gastrointestinal cancer, carcinoid tumors